U.S. Markets open in 5 hrs 38 mins

Sucampo Pharmaceuticals (SCMP) Crumbles: Stock Falls by 6.3%

Zacks Equity Research

Sucampo Pharmaceuticals, Inc. (SCMP) saw a big move last session, as the company’s shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for SCMP, as the stock is now up 0.5% in the past one-month time frame.

This medical drugs company has seen a flat record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases). The consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

SCMP currently has a Zacks Rank #3 (Hold) while it has an Earnings ESP of 0.00%.

Investors interested in the medical drugs industry may consider better-ranked stocks like Endocyte, Inc. (ECYT), Forest Laboratories Inc. (FRX) and WuXi PharmaTech (Cayman) Inc. (WX). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Zacks Investment Research